Clinical case: Effectiveness of combined therapyOrlistat and Irbesartan at the Metabolic syndrome patient with Arterial hypertension

Authors: Ivanov KP¹, Mychka V.B.¹, Kirillova MY.¹, Chazova I.E.¹, Ivanov KP¹, Mychka VB¹, Kirillov MJ¹, Chazova IE¹
Affiliations:
Issue: Vol 6, No 1 (2009)
Pages: 64-66
Section: Articles
URL: https://journals.eco-vector.com/2075-082X/article/view/33075
DOI: https://doi.org/10.26442/SG33075
ID: 33075

Cite item

Full Text

blood pressure, combination therapy, orlistat and irbesartan

Чазова И.Е., Мычка В.Б. Метаболический синдром. М., 2008.
Reaven G, Lithell H, Landsberg L. Hypertension and associated metabolic abnormalities - the role of insulin resistance and the sympatoadrenal system. N Engl J Med 1996; 334: 374-81
Filer JS. Leptin resistance and obesity. Presented at the 60 th Scientific Sessions of the american diabetes association. June 13, 2000. San-Antonio, Texas.
Диагностика и лечение метаболического синдрома. Российские рекомендации. Кардиоваск. тер. и проф. Прил. 2. 2007; 6(6).
Диагностика и лечение артериальной гипертензии. Российские рекомендации. Кардиоваск. тер. и проф. Прил. 2. 2008; 7(6).

Supplementary Files

Action

1. JATS XML